Reich HN, Troyanov S, Scholey JW, Cattran DC. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18:3177–83.

Article  PubMed  CAS  Google Scholar 

Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, et al. Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med. 2015;373:2225–36.

Article  PubMed  CAS  Google Scholar 

Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, et al. Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA. 2017;318:432–42.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rodrigues JC, Haas M, Reich HN. IgA nephropathy. Clin J Am Soc Nephrology: CJASN. 2017;12:677.

Article  CAS  Google Scholar 

Luo M-N, Pan Q, Huang Z-Q, Li S-M, Xu Y-Z, Liu H. -f. IgA nephropathy patients with partial crescent formation benefit from immunosuppressants: evidence from repeat renal biopsy. Discov Med. 2020;30:19–25.

PubMed  Google Scholar 

Rafieian-Kopaei M, Baradaran A, Nasri H. Significance of extracapillary proliferation in IgA-nephropathy patients with regard to clinical and histopathological variables. Hippokratia. 2013;17:258.

PubMed  PubMed Central  CAS  Google Scholar 

Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91:1014–21.

Article  PubMed  Google Scholar 

Herlitz LC, Charles Jennette J. Histopathology of glomerular diseases. Cham: Glomerulonephritis Springer; 2019.

Book  Google Scholar 

Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. Newcastle-Ottawa quality assessment scale cohort studies. University of Ottawa; 2014.

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

Article  PubMed  Google Scholar 

Copas J, Shi JQ. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics. 2000;1:247–62.

Article  PubMed  CAS  Google Scholar 

Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane database of systematic reviews. 2019;2019.

Haas M, Verhave JC, Liu Z-H, Alpers CE, Barratt J, Becker JU, et al. A multicenter study of the predictive value of crescents in IgA nephropathy. J Am Soc Nephrology: JASN. 2017;28:691.

Article  PubMed  CAS  Google Scholar 

Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X, et al. A validation study of crescents in predicting ESRD in patients with IgA nephropathy. J Translational Med. 2018;16:1–8.

Article  Google Scholar 

Park S, Baek CH, Park S-K, Kang HG, Hyun HS, Park E, et al. Clinical significance of crescent formation in IgA nephropathy–a multicenter validation study. Kidney Blood Press Res. 2019;44:22–32.

Article  PubMed  CAS  Google Scholar 

Peng W, Tang Y, Tan L, Qin W. Crescents and global glomerulosclerosis in Chinese IgA nephropathy patients: a five-year follow-up. Kidney Blood Press Res. 2019;44:103–12.

Article  PubMed  CAS  Google Scholar 

Lin Z, Liu L, Zhang R, Lin X, Lu F, Bao K, et al. Volume of crescents affects prognosis of IgA nephropathy in patients without obvious chronic renal pathology. Am J Nephrol. 2021;52:507–18.

Article  PubMed  CAS  Google Scholar 

Chen Y, Yang Y, Liang Y, Liu M, Xiao W, Hu X. Retrospective analysis of crescent score in clinical prognosis of IgA nephropathy. Open Med. 2022;17:205–15.

Article  CAS  Google Scholar 

Du Y, Chen S, Wang F, Zhang P, Liu M, Liu C, et al. The significance of crescents on the clinical features and outcomes of primary immunoglobin a nephropathy. Front Med. 2022;9:864667.

Article  Google Scholar 

Ossareh S, Nazemzadeh N, Asgari M, Bagherzadegan H, Afghahi H. The added value of crescents on Oxford classification score in risk stratification of end-stage kidney disease in patients with IgA nephropathy. Iran J Kidney Dis. 2022;16.

Ruan Y, Hong F, Wu J, Lin M, Wang C, Lian F, et al. Clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy with crescents. J Nephrol. 2022;35:1113–21.

Article  PubMed  CAS  Google Scholar 

Di D, Liu L, Wang Y, Yang Y, Jiang S, Li W. Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation. Ren Fail. 2023;45:2226257.

Article  PubMed  PubMed Central  Google Scholar 

Lv J, Yang Y, Zhang H, Chen W, Pan X, Guo Z, et al. Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study. J Am Soc Nephrology: JASN. 2013;24:2118.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang W, Zhou Q, Hong L, Chen W, Yang S, Yang Q et al. Clinical outcomes of IgA nephropathy patients with different proportions of crescents. Medicine. 2017;96.

Ma F, Liu L, Dong R, Yang X, Wei L, Li L, et al. Renal survival and risk factors in IgA nephropathy with crescents. Int Urol Nephrol. 2020;52:1507–16.

Article  PubMed  CAS  Google Scholar 

of the International AWG, Network IN, Cattran DC, Coppo R, Cook HT, Feehally J, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–45.

Article  Google Scholar 

Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, et al. Validation of the Oxford classification of IgA nephropathy. Kidney Int. 2011;80:310–7.

Article  PubMed  Google Scholar 

Le W, Zeng C-H, Liu Z, Liu D, Yang Q, Lin R-X, et al. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol. 2012;13:1–8.

Article  Google Scholar 

Shi S-F, Wang S-X, Jiang L, Ji-Cheng L, Liu L-J, Chen Y-Q, et al. Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrology: CJASN. 2011;6:2175.

Article  CAS  Google Scholar 

Lee MJ, Kim SJ, Oh HJ, Ko KI, Koo HM, Kim CH, et al. Clinical implication of crescentic lesions in immunoglobulin A nephropathy. Nephrol Dialysis Transplantation. 2014;29:356–64.

Article  CAS  Google Scholar 

Katafuchi R, Ninomiya T, Nagata M, Mitsuiki K, Hirakata H. Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation. Clin J Am Soc Nephrology: CJASN. 2011;6:2806.

Article  CAS  Google Scholar 

Walsh M, Sar A, Lee D, Yilmaz S, Benediktsson H, Manns B, et al. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrology: CJASN. 2010;5:425.

Article  CAS  Google Scholar 

Shima Y, Nakanishi K, Hama T, Mukaiyama H, Togawa H, Hashimura Y, et al. Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol. 2012;27:783–92.

Article  PubMed  Google Scholar 

Edström Halling S, Söderberg MP, Berg UB. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Nephrol Dialysis Transplantation. 2012;27:715–22.

Article  Google Scholar 

Zhao Y, Lin H, Xu R, He Y. Correlation analysis of 2017 Oxford classification of IgA nephropathy and renal prognosis. Chin J IntegrTradit West Med. 2019;20:804–7.

Google Scholar 

Shi SF, Wang SX, Jiang L, Lv JC, Liu LJ, Chen YQ, et al. Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol. 2011;6:2175–84.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wu H, Xia Z, Gao C, Zhang P, Yang X, Wang R, et al. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study. BMC Nephrol. 2020;21:247.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lv J, Shi S, Xu D, Zhang H, Troyanov S, Cattran DC, et al. Evaluation of the Oxford classification of IgA nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2013;62:891–9.

Article